NEW YORK (GenomeWeb) – Premaitha Health said today that it has named Adgenix as the exclusive distributor of its Iona cell-free DNA prenatal screening test in France.
In addition, Premaitha, based in Manchester, UK, said that Adgenix has already signed up its first laboratory customer, inking a contract for a minimum of three years to supply LaboSud with the assay.
The Iona test estimates the risk of a fetus being affected by Down syndrome and other serious genetic conditions by analyzing cell-free fetal DNA from a maternal blood sample. The test enables clinical laboratories to offer their own decentralized non-invasive prenatal testing in house, thereby providing faster results to the patient.
"Securing our first French partnership with LaboSud and Adgenix is an important step forward for us as we continue to expand the reach of the Iona test across Europe," Premaitha CEO Stephen Little said in a statement. "Our NIPT test provides more accurate and faster results that will benefit more pregnant women in France."
LaboSud is a private group of reference laboratories in the Montpellier region of France. It provides medical and diagnostic laboratory services to clinics and hospitals from the Languedoc-Roussillon region with plans to expand throughout the country.